Seth Harmon is the Senior Vice President of Finance and Accounting at Viridian Therapeutics ORS Inc., a position he has held since joining the company in 2019. With over 20 years of experience in financial management and strategic planning, Seth has become an integral part of Viridian's leadership team. Before joining Viridian, he served as the Vice President of Finance at BioGenix Pharmaceuticals, where he was instrumental in overseeing the company's financial operations and driving its growth during a critical expansion phase. At Viridian Therapeutics, Seth is responsible for overseeing all aspects of the company's financial strategy, including budgeting, forecasting, and financial reporting. His expertise has been crucial in helping Viridian navigate the complex financial landscape of the biotechnology industry. Under his leadership, the company has successfully raised significant capital to fund its research and development initiatives, positioning Viridian as a leader in the development of innovative therapies for rare diseases. Seth's strategic vision and financial acumen have been key factors in the company's ability to achieve its ambitious goals and maintain a strong financial position. In addition to his professional achievements, Seth is known for his commitment to mentoring young professionals in the finance and accounting fields. He actively participates in industry conferences and workshops, sharing his knowledge and insights with the next generation of financial leaders. Seth holds an MBA from the Wharton School of the University of Pennsylvania and a Bachelor's degree in Accounting from the University of Michigan. His dedication to excellence and his ability to drive financial success have made him a respected figure in the biotechnology industry.